The short version
13 companies supply this market — deep enough that no single failure threatens the supply. The brand price has held steady around $6.28 per unit over the past year. Generic versions run $3.58 per unit — 1.8× cheaper. Historically, drugs in this position went on to a new shortage within 90 days about 0.4% of the time — roughly 3× the typical drug (0.1%).